Linking Clozapine/Norclozapine Ratio with Glial Marker in Patients With Treatment Resistant Schizophrenia

MLA

Ariel Graff-Guerrero, et al. “Linking Clozapine/Norclozapine Ratio with Glial Marker in Patients With Treatment Resistant Schizophrenia.” Biological Psychiatry, vol. 89, May 2021, p. S252. EBSCOhost, https://doi.org/10.1016/j.biopsych.2021.02.631.

APA

Ariel Graff-Guerrero, Edgardo Torres Carmona, Sofia Chavez, Gary Remington, Julia Kim, Shinichiro Nakajima, Philip Gerretsen, Fumihiko Ueno, Yusuke Iwata, Wanna Mar, & Fernando Caravaggio. (2021). Linking Clozapine/Norclozapine Ratio with Glial Marker in Patients With Treatment Resistant Schizophrenia. Biological Psychiatry, 89, S252. https://doi.org/10.1016/j.biopsych.2021.02.631

Chicago

Ariel Graff-Guerrero, Edgardo Torres Carmona, Sofia Chavez, Gary Remington, Julia Kim, Shinichiro Nakajima, Philip Gerretsen, et al. 2021. “Linking Clozapine/Norclozapine Ratio with Glial Marker in Patients With Treatment Resistant Schizophrenia.” Biological Psychiatry 89 (May): S252. doi:10.1016/j.biopsych.2021.02.631.